Table 1.
Prostate cancer distribution according to the Gleason score and the PI-RADS v1 score (based on 2012 ESUR recommendations)
| Gleason score 6 (3+3) |
Gleason score 7 (3+4) |
Gleason score 7 (4+3) |
Gleason score 8 (4+4) |
Gleason score 9 (4+5) |
Gleason 9 (5+4) |
|
|---|---|---|---|---|---|---|
| PI-RADS 1 | 8 (8.79%) <0.5 cm3 – 8 ≥0.5 cm3 – 0 |
1 (1.10%) <0.5 cm3 – 1 ≥0.5 cm3 – 0 |
– | – | – | – |
| PI-RADS 2 | 8 (8.79%) <0.5 cm3 – 6 ≥0.5 cm3 – 2 |
3 (3.30%) <0.5 cm3 – 2 ≥0.5 cm3 – 1 |
– | – | – | – |
| PI-RADS 3 | 27 (29.67%) <0.5 cm3 – 16 ≥0.5 cm3 – 11 |
3 (3.30%) <0.5 cm3 – 1 ≥0.5 cm3 – 2 |
2 (2.20%) <0.5 cm3 – 2 ≥0.5 cm3 – 0 |
4 (4.40%) <0.5 cm3 – 3 ≥0.5 cm3 – 1 |
1 (1.10%) <0.5 cm3 – 1 ≥0.5 cm3 – 0 |
– |
| PI-RADS 4 | 13 (14.29%) <0.5 cm3 – 9 ≥0.5 cm3 – 4 |
4 (4.40%) <0.5 cm3 – 0 ≥0.5 cm3 – 4 |
1 (1.10%) <0.5 cm3 – 0 ≥0.5 cm3 – 1 |
1 (1.10%) <0.5 cm3 – 0 ≥0.5 cm3 – 1 |
1 (1.10%) <0.5 cm3 – 1 ≥0.5 cm3 – 0 |
1 (1.10%) <0.5 cm3 – 1 ≥0.5 cm3 – 0 |
| PI-RADS 5 | 4 (4.40%) <0.5 cm3 – 2 ≥0.5 cm3 – 2 |
4 (4.40%) <0.5 cm3 – 0 ≥0.5 cm3 – 4 |
4 (4.40%) <0.5 cm3 – 1 ≥0.5 cm3 – 3 |
1 (1.10%) <0.5 cm3 – 0 ≥0.5 cm3 – 1 |
– | – |